Week of February 26 - 04, 2017


Radiation Fibrosis Syndrome

Radiation fibrosis syndrome is a common late side effect of radiation in the treatment of head and neck cancer. 

Trismus

Information about the side effect trismus and how it is treated. 

Proton Therapy for Head & Neck Cancers: Webinar

This webinar provides an introduction to the treatment of head and neck cancers, with a focus on radiation therapy and specifically the treatment of head and neck cancers with proton therapy.

Rucaparib (Rubraca™)

Rucaparib is a PARP (poly ADP ribose polymerase) inhibitor. Cancers related to BRCA 1 or 2 mutations seem to rely on PARP to repair damaged DNA in cancer cells, allowing them to continue to divide. By inhibiting PARP, tumor growth may be slowed or stopped. A blood test is required prior to starting treatment with rucaparib to determine if you have a BRCA mutation.

Blogs

The Conception of OncoLink – A Perspective
by Carolyn Vachani, MSN, RN, AOCN
March 1, 2012

“No Shave November”
by Angelo Melendez
November 10, 2016
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
R
S
T
U
V
X
Y
Z
#
 
A
B
C
E
F
G
H
K
L
M
N
O
P
R
S
T
U
V
 
 
Stay informed with the latest information from OncoLink!   Subscribe to OncoLink eNews
View our newsletter archives